2020
DOI: 10.1080/15513815.2019.1710789
|View full text |Cite
|
Sign up to set email alerts
|

Extending Phenotypic Spectrum of 17q22 Microdeletion: Growth Hormone Deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 14 publications
0
4
0
Order By: Relevance
“…With the development of craniofacial genetics, many rare genetic diseases have also been shown to have specific facial features, such as the broad nasal bridge in 15q11-q13 duplication syndrome, the maxillary hypoplasia in 17q22 microdeletion, the wide and depressed nasal bridge in Helsmoortel-van der AA syndrome, etc. [13][14][15]. These studies show the specificity of fetal facial features.…”
Section: Introductionmentioning
confidence: 53%
See 1 more Smart Citation
“…With the development of craniofacial genetics, many rare genetic diseases have also been shown to have specific facial features, such as the broad nasal bridge in 15q11-q13 duplication syndrome, the maxillary hypoplasia in 17q22 microdeletion, the wide and depressed nasal bridge in Helsmoortel-van der AA syndrome, etc. [13][14][15]. These studies show the specificity of fetal facial features.…”
Section: Introductionmentioning
confidence: 53%
“…All examinations have been performed and diagnosed before the research by one or two ultrasound specialists with more than five years of experience. Overall, our datasets contain 845 normal pregnancy images and 275 genetic disease images from 667 cases, with a gestational age distribution of 14.8 ± 2.6 (range [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27]. Details on the development set and test set are described in Table 1.…”
Section: Data Acquisitionmentioning
confidence: 99%
“…Individuals with 1.8–2.5 Mb microdeletions of the 17q22 region have been reported in the literature. 60 , 61 , 62 , 63 , 64 An important causal gene related to the clinical manifestations of 17q22 microdeletion is NOG (MIM: 602991 ). When it is included in the microdeletion, NOG -related bone and joint features such as symphalangism, conductive hearing loss, and joint contractures are present, as are visual impairment and facial dysmorphic features.…”
Section: Discussionmentioning
confidence: 99%
“… 60 Among the reported individuals with 17q22 contiguous microdeletions, six had loss of SRSF1 and presented with syndromic ID. 60 , 61 , 62 , 63 More recently, Pang et al. reported a family with 1.6 Mb microdeletion in chromosome 17q22 with NOG -related symphalangism spectrum disorder including conductive hearing loss, proximal symphalangism of the fifth fingers, small palpebral fissures, broadened hemicylindrical nose with a bulbous tip, amblyopia, and strabismus without ID or any other neurodevelopmental abnormalities.…”
Section: Discussionmentioning
confidence: 99%